Filter
2411
Filtered Results: 2411
Text search:
drug
regulation
Featured
Recommendations
187
New Publications
665
Language
Document type
No document type
1413
Studies & Reports
409
Guidelines
309
Manuals
120
Strategic & Response Plan
89
Fact sheets
23
Training Material
21
Situation Updates
14
Infographics
5
Brochures
4
Resource Platforms
4
Countries / Regions
India
107
Kenya
87
Global
80
Western and Central Europe
65
Nigeria
57
Uganda
54
South Africa
53
Ethiopia
53
Liberia
43
Sierra Leone
42
Tanzania
42
Ghana
41
Africa
40
Bangladesh
40
Latin America and the Carribbean
39
Nepal
38
Zambia
37
Malawi
33
Eastern Europe
30
Ukraine
28
Myanmar / Burma
28
Philippines
25
Rwanda
24
Namibia
24
Indonesia
24
South–East Asia Region
23
Zimbabwe
19
Asia
18
Lesotho
17
Cambodia
16
Russia
16
Syria
15
Botswana
15
Eswatini/ Swaziland
14
Congo, Democratic Republic of
11
Senegal
10
Pakistan
10
Mozambique
9
Venezuela
9
Thailand
8
Middle East and North Africa
8
Brazil
8
Georgia
8
Cameroon
7
Albania
7
USA
7
Haiti
7
Germany
7
Eastern Europe and Central Asia
7
Vietnam
7
Colombia
6
Burkina Faso
6
West and Central Africa
6
China
5
Laos
5
Western Pacific Region
5
East and Southern Africa
5
Sudan
5
Iraq
5
Tajikistan
4
El Salvador
4
Chile
4
Peru
4
Guinea
4
Argentina
4
Lebanon
4
Moldova
4
South Sudan
4
North Macedonia
3
Mexico
3
Turkey
3
Benin
3
Kyrgyzstan
3
Afghanistan
3
Jordan
3
Paraguay
3
Bolivia
3
Sri Lanka
3
Libya
3
Bhutan
3
Kazakhstan
2
Iran
2
Fiji
2
Uzbekistan
2
Morocco
2
Hungary
2
Portugal
2
Spain
2
Papua New Guinea
2
Yemen
2
Poland
2
Honduras
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Singapore
1
Estonia
1
Mongolia
1
Qatar
1
Italy
1
Lithuania
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Belarus
1
Southern Africa
1
Nicaragua
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Angola
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
962
Clinical Guidelines
163
Public Health
139
Women & Child Health
74
Key Resources
56
Pharmacy & Technologies
46
Capacity Building
22
Toolboxes
Mental Health
245
HIV
224
AMR
197
TB
159
Pharmacy
121
COVID-19
117
Rapid Response
59
NCDs
53
Planetary Health
52
Caregiver
51
NTDs
38
Ebola
35
Global Health Education
32
Refugee
30
Conflict
30
Disability
23
Health Financing Toolbox
16
Specific Hazards
14
Polio
11
Zika
8
Natural Hazards
7
Social Ethics
7
Cholera
5
Int. J. Environ. Res. Public Health 2020, 17(23), 8849; https://doi.org/10.3390/ijerph17238849
The aim of building climate resilient and environmentally sustainable health care facilities is: (a) to enhance their capacity to protect and improve the health of their target communities in an unstable...
In emergency or humanitarian settings, mobile clinics are used to bring essential lifesaving health care to communities affected by crises. Though there are standard emergency benefit packages for health services during emergencies, there are however no agreed or standard way of running mobile clini...
The Region of the Americas comprises 46 countries and territories and Brazil and Peru are among the WHO high- TB burden
countries. T o illustrate the recent increase in TB incidence in the region, we selected 12 countries from Latin America (Argentina,
Brazil, Chile, Colombia, Ecuador, El Salvador...
The COVID-19 pandemic is having a major impact on the mental health of populations in the Americas. Studies
show high rates of depression and anxiety, among other psychological symptoms, particularly among women, young
people, those with pre-existing mental health conditions, health workers, and p...
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered ...
Human rights-based approaches to the creation of knowledge involve application of human rights principles to both the content and process of knowledge creation. Human rights-based approaches have special significance for the sexual and reproductive health and rights (SRHR) of all people, in particul...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
14 June 2022.
The aim of this document is to provide concise advice to public health authorities and guide their prevention, awareness-raising and behaviour change interventions before, during and after upcoming summer events.
Assessment Report
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease. Endemic in 21 Latin American countries, the disease can be transmitted by vector insects called triatomines — also known as “kissing bugs” —, foods or beverages contaminated with th...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
